Better High-Yielding Dividend Stock: Realty Income vs. Pfizer
Dividend stocks are a great way for investors to generate passive income that can be more reliable and predictable than investing in stocks for pure appreciation. While there are no guarantees in the stock market, investors who carefully analyze a company's cash flows and earnings should be able to get a pretty good idea of whether a company can keep paying its Dividend, and if it is poised to gradually increase its quarterly Dividend each year.
Both Realty Income (NYSE: O) and (NYSE: PFE) are two companies with high-yielding dividends and that have paid dividends for many years. Let's take a look at each and see which one is the better dividend stock to own.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Stock
€22.06
1.310%
We see a rather positive sentiment for Pfizer Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 29 € shows a positive potential of 31.49% compared to the current price of 22.06 € for Pfizer Inc..
